Vaccines Archives

Health J. Emory Parker and Andrew Joseph

A third Covid autumn is upon us. Here’s a look at where we stand

Health Sarah Owermohle

The Biden administration is pushing another round of Covid boosters. Who’s listening?

Health Matthew Herper

FDA authorizes Pfizer and Moderna Covid boosters targeted against Omicron strains

Matt's Take Matthew Herper

Moderna’s suing Pfizer? Wow! OK, now take a deep breath.

Biotech Jason Mast

Moderna sues Pfizer and BioNTech over Covid-19 vaccine

Pharmalot Ed Silverman

Pharmalittle: Moderna sues Pfizer over Covid-19 vax patents; White House directs quick access to federally funded research

Pharmalot Ed Silverman

Pharmalittle: Biden plan to stretch monkeypox vax supplies hits problems; Pfizer and BioNTech ask FDA to clear Covid shot for variants

Biotech Jason Mast

Merck, a loser in the Covid vaccine race, reinvests in mRNA through a Cambridge startup

Health Andrew Joseph

A complicated fall vaccine campaign: Updated Covid boosters, flu shots, and how to time the jabs

Health Andrew Joseph

A treatment for monkeypox was approved under the FDA’s ‘Animal Rule.’ Here’s what that means

First Opinion Caitlin Rivers and Tom Inglesby

FDA needs to fully review ACAM2000 before allowing its widespread use as a monkeypox vaccine

First Opinion Philip Krause and Luciana L. Borio

Will low-dose vaccination stretch the monkeypox vaccine supply, or backfire?

First Opinion Martha Rebour and Purvi Parikh

The U.S. must fully fund global polio eradication efforts

Pharmalot Ed Silverman

Pharmalittle: U.S. government blunder contributed to monkeypox vax shortage; Amgen to pay $4 billion for ChemoCentryx

Matt's Take Matthew Herper

Can we really get better Covid vaccines? There are big hurdles, but some hope

Politics Lev Facher

White House summit sets lofty goals for new Covid vaccines — but largely sidesteps questions of funding

Exclusive Matthew Herper and Lev Facher

White House to launch effort to develop next generation of Covid vaccines

First Opinion Thomas B. Cueni and Richard Hatchett

Poorer nations need assurances of dedicated vaccine supplies before the next pandemic

Pharmalot Ed Silverman

Pharma and patient advocates offer competing visions for achieving vaccine equity during pandemics

Health Helen Branswell

Novavax’s Covid-19 vaccine wins backing of CDC advisory panel

Health Helen Branswell

NYC will use a one-dose monkeypox vaccine strategy to stretch supplies, despite FDA, CDC warnings against the move

The Readout LOUD Damian Garde and Adam Feuerstein

Listen: CRISPR for the heart, biotech’s recovery, & what it means to be a ‘hot girl’

Health Matthew Herper

FDA authorizes Novavax Covid vaccine, in hopes the traditional shot will convince holdouts

First Opinion Jorge A. Caballero

The FDA owes parents an explanation about why it delayed authorizing Moderna’s Covid-19 vaccine for young kids

First Opinion Paul Chaplin

Vaccines

Most Read

Polio in New York: A call to action for U.S. pediatricians and public health to work together

Pfizer’s experimental RSV vaccine protects older adults in study

Pharmalittle: AstraZeneca may exit the vaccine business; Bavarian Nordic looks at expired monkeypox vax doses to boost supplies

U.S. plan to stretch monkeypox vaccine supply already hitting hurdles

Pfizer seeks authorization for updated Covid vaccine, without fresh clinical trial data

Investing in health workers can help close the vaccination gap — and improve global health

Despite overall decline, late-stage cervical cancer cases are rising

White House, facing pressure from activists, to accelerate rollout of monkeypox treatments and vaccines

All Coverage

A third Covid autumn is upon us. Here’s a look at where we stand

The Biden administration is pushing another round of Covid boosters. Who’s listening?

FDA authorizes Pfizer and Moderna Covid boosters targeted against Omicron strains

Moderna’s suing Pfizer? Wow! OK, now take a deep breath.

Moderna sues Pfizer and BioNTech over Covid-19 vaccine

Pharmalittle: Moderna sues Pfizer over Covid-19 vax patents; White House directs quick access to federally funded research

Pharmalittle: Biden plan to stretch monkeypox vax supplies hits problems; Pfizer and BioNTech ask FDA to clear Covid shot for variants

Merck, a loser in the Covid vaccine race, reinvests in mRNA through a Cambridge startup

A complicated fall vaccine campaign: Updated Covid boosters, flu shots, and how to time the jabs

A treatment for monkeypox was approved under the FDA’s ‘Animal Rule.’ Here’s what that means

FDA needs to fully review ACAM2000 before allowing its widespread use as a monkeypox vaccine

Will low-dose vaccination stretch the monkeypox vaccine supply, or backfire?

The U.S. must fully fund global polio eradication efforts

Pharmalittle: U.S. government blunder contributed to monkeypox vax shortage; Amgen to pay $4 billion for ChemoCentryx

Can we really get better Covid vaccines? There are big hurdles, but some hope

White House summit sets lofty goals for new Covid vaccines — but largely sidesteps questions of funding

White House to launch effort to develop next generation of Covid vaccines

Poorer nations need assurances of dedicated vaccine supplies before the next pandemic

Pharma and patient advocates offer competing visions for achieving vaccine equity during pandemics

Novavax’s Covid-19 vaccine wins backing of CDC advisory panel

NYC will use a one-dose monkeypox vaccine strategy to stretch supplies, despite FDA, CDC warnings against the move

Listen: CRISPR for the heart, biotech’s recovery, & what it means to be a ‘hot girl’

FDA authorizes Novavax Covid vaccine, in hopes the traditional shot will convince holdouts

The FDA owes parents an explanation about why it delayed authorizing Moderna’s Covid-19 vaccine for young kids

The monkeypox vaccine underscores the value of U.S. investments in preparedness

You've been selected! STAT+ for less than $2/day

Subscribe to STAT+ for less than $2 per day